Immunosuppressant Switch Cuts Skin Cancer Post-TransplantRenal and Urology NewsIn kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with…

PsychCentral.comWhy people don't perform under stressTimes of IndiaIn order to test the different stress hormones, the cognition psychologists used three substances – a placebo, the stress hormone hydrocortisone and yohimbine, which ensures that th…

PsychCentral.comWhy people don't perform well when stressedNewstrack IndiaIn order to test the different stress hormones, the cognition psychologists used three substances – a placebo, the stress hormone hydrocortisone and yohimbine, which ensures …

Stress Hormones Switch Off Areas of The BrainBiomed Middle EastThe researchers say that the interaction of the stress hormones hydrocortisone and noradrenaline shut down the activity of brain regions for goal-directed behaviour. The brain regions respo…

Immunosuppressant Switch Cuts Skin Cancer Post-TransplantDoctors LoungeIn kidney-transplant patients with at least one cutaneous squamous-cell carcinoma, switching immunosuppressants (from calcineurin inhibitors to sirolimus) is associated with increas…

Force of habit: Stress hormones switch off areas of the brain for goal …Eureka! Science NewsThe researchers have now reported in the Journal of Neuroscience that the interaction of the stress hormones hydrocortisone and noradrenaline shut down the ac…

Force of habit: Stress hormones switch off areas of the brain for goal …Medical XpressThe researchers have now reported in the Journal of Neuroscience that the interaction of the stress hormones hydrocortisone and noradrenaline shut down the activity…

OncLiveFDA Approves Everolimus (Afinitor) for Metastatic Breast CancerCancer NetworkThe US Food and Drug Administration (FDA) approved the mTOR inhibitor everolimus (Afinitor) last week for use in postmenopausal women with HER2-negative, hormone-recept…

TCTMDXience V Noninferior to Cypher for Primary PCITCTMDA second-generation everolimus-eluting stent (EES) is noninferior to a first-generation sirolimus-eluting stent (SES) for treating acute myocardial infarction (MI), according to randomized data pu…

FDA approves Novartis Afinitor to treat advanced breast cancerPharmaceutical Business ReviewNovartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative…